Business · 28/06/2024
FDA Releases Draft Guidance on Diversity Action Plans for Clinical Studies
The FDA is releasing a draft guidance to improve enrollment of participants from underrepresented populations in clinical studies, as mandated by the Food and Drug Omnibus Reform Act of 2022.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →